Loading clinical trials...
Loading clinical trials...
The objective of this intervention study is to examine the effect of n-3 LCPUFA on growth and body composition, intestinal health and microbiotic composition, immune function and risk markers for late...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Copenhagen
Collaborators
NCT05967689 · Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss
NCT07669168 · Health Services Accessibility, Rural Health, and more
NCT07333521 · Isolated Non-acquired Growth Hormone Deficiency
NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more
Dept. of Human Nutrition
Copenhagen, Frederiksberg C
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions